Stocks · Health care · Biological Products, (No Diagnostic Substances)

LENZ Therapeutics, Inc.

LENZ Clue Score49
United States Fiscal year ends December CIK 0001815776
3.65
+3.26%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
3.65 on 9 Oct 2026
42 23 4 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $38.61 14 Oct 2025 $38.80 15 Oct 2025 $41.85 16 Oct 2025 $40.45 17 Oct 2025 $38.26 20 Oct 2025 $36.31 21 Oct 2025 $33.56 22 Oct 2025 $32.70 23 Oct 2025 $31.38 24 Oct 2025 $31.97 27 Oct 2025 $31.29 28 Oct 2025 $30.81 29 Oct 2025 $30.64 30 Oct 2025 $30.46 31 Oct 2025 $29.72 3 Nov 2025 $27.93 4 Nov 2025 $28.05 5 Nov 2025 $21.47 6 Nov 2025 $22.96 7 Nov 2025 $22.97 10 Nov 2025 $23.19 11 Nov 2025 $26.45 12 Nov 2025 $25.50 13 Nov 2025 $26.49 14 Nov 2025 $25.60 17 Nov 2025 $25.70 18 Nov 2025 $27.23 19 Nov 2025 $28.40 20 Nov 2025 $27.72 21 Nov 2025 $29.56 24 Nov 2025 $31.94 25 Nov 2025 $29.88 26 Nov 2025 $30.72 28 Nov 2025 $30.52 1 Dec 2025 $30.40 2 Dec 2025 $27.31 3 Dec 2025 $28.00 4 Dec 2025 $27.90 5 Dec 2025 $26.72 8 Dec 2025 $26.71 9 Dec 2025 $26.45 10 Dec 2025 $25.04 11 Dec 2025 $24.50 12 Dec 2025 $18.14 15 Dec 2025 $17.08 16 Dec 2025 $16.70 17 Dec 2025 $16.37 18 Dec 2025 $17.07 19 Dec 2025 $18.00 22 Dec 2025 $17.62 23 Dec 2025 $16.89 24 Dec 2025 $17.14 26 Dec 2025 $16.87 29 Dec 2025 $16.52 30 Dec 2025 $16.12 31 Dec 2025 $16.00 2 Jan 2026 $16.00 5 Jan 2026 $16.48 6 Jan 2026 $16.85 7 Jan 2026 $16.31 8 Jan 2026 $15.24 9 Jan 2026 $14.87 12 Jan 2026 $15.57 13 Jan 2026 $16.60 14 Jan 2026 $18.59 15 Jan 2026 $18.14 16 Jan 2026 $18.29 20 Jan 2026 $19.38 21 Jan 2026 $19.48 22 Jan 2026 $21.27 23 Jan 2026 $20.44 26 Jan 2026 $20.18 27 Jan 2026 $19.39 28 Jan 2026 $18.65 29 Jan 2026 $17.78 30 Jan 2026 $15.82 2 Feb 2026 $16.30 3 Feb 2026 $15.53 4 Feb 2026 $14.62 5 Feb 2026 $13.97 6 Feb 2026 $14.22 9 Feb 2026 $14.01 10 Feb 2026 $13.66 11 Feb 2026 $13.51 12 Feb 2026 $12.97 13 Feb 2026 $12.88 17 Feb 2026 $13.04 18 Feb 2026 $12.77 19 Feb 2026 $12.05 20 Feb 2026 $11.59 23 Feb 2026 $11.89 24 Feb 2026 $12.82 25 Feb 2026 $13.22 26 Feb 2026 $13.52 27 Feb 2026 $13.49 2 Mar 2026 $13.68 3 Mar 2026 $13.15 4 Mar 2026 $12.96 5 Mar 2026 $12.06 6 Mar 2026 $11.67 9 Mar 2026 $12.30 10 Mar 2026 $11.94 11 Mar 2026 $12.02 12 Mar 2026 $11.82 13 Mar 2026 $12.15 16 Mar 2026 $11.74 17 Mar 2026 $12.50 18 Mar 2026 $11.72 19 Mar 2026 $11.49 20 Mar 2026 $10.48 23 Mar 2026 $11.00 24 Mar 2026 $9.03 25 Mar 2026 $9.07 26 Mar 2026 $8.94 27 Mar 2026 $8.40 30 Mar 2026 $8.29 31 Mar 2026 $9.15 1 Apr 2026 $9.35 2 Apr 2026 $9.67 6 Apr 2026 $9.61 7 Apr 2026 $9.71 8 Apr 2026 $9.45 9 Apr 2026 $9.29 10 Apr 2026 $9.07 13 Apr 2026 $9.63 14 Apr 2026 $9.90 15 Apr 2026 $9.58 16 Apr 2026 $9.64 17 Apr 2026 $10.18 20 Apr 2026 $10.13 21 Apr 2026 $9.87 22 Apr 2026 $9.99 23 Apr 2026 $9.15 24 Apr 2026 $9.38 27 Apr 2026 $9.76 28 Apr 2026 $9.29 29 Apr 2026 $9.05 30 Apr 2026 $8.98 1 May 2026 $8.88 4 May 2026 $9.28 5 May 2026 $9.07 6 May 2026 $9.68 7 May 2026 $9.72 8 May 2026 $10.06 11 May 2026 $9.99 12 May 2026 $7.91 13 May 2026 $8.05 14 May 2026 $7.29 15 May 2026 $7.34 18 May 2026 $6.90 19 May 2026 $6.65 20 May 2026 $7.20 21 May 2026 $7.52 22 May 2026 $7.55 26 May 2026 $7.75 27 May 2026 $7.73 28 May 2026 $7.99 29 May 2026 $7.78 1 Jun 2026 $7.44 2 Jun 2026 $7.13 3 Jun 2026 $7.01 4 Jun 2026 $7.20 5 Jun 2026 $7.01 8 Jun 2026 $6.72 9 Jun 2026 $6.79 10 Jun 2026 $6.58 11 Jun 2026 $6.50 12 Jun 2026 $6.77 15 Jun 2026 $6.63 16 Jun 2026 $6.52 17 Jun 2026 $6.34 18 Jun 2026 $6.15 22 Jun 2026 $5.82 23 Jun 2026 $5.75 24 Jun 2026 $5.58 25 Jun 2026 $5.51 26 Jun 2026 $5.82 29 Jun 2026 $5.76 30 Jun 2026 $5.68 1 Jul 2026 $5.79 2 Jul 2026 $5.89 6 Jul 2026 $5.60 7 Jul 2026 $5.90 8 Jul 2026 $6.13 9 Jul 2026 $5.79 10 Jul 2026 $5.59 13 Jul 2026 $5.23 14 Jul 2026 $4.93 15 Jul 2026 $4.99 16 Jul 2026 $4.88 17 Jul 2026 $5.18 20 Jul 2026 $4.96 21 Jul 2026 $5.16 22 Jul 2026 $5.34 23 Jul 2026 $5.05 24 Jul 2026 $5.48 27 Jul 2026 $5.70 28 Jul 2026 $5.88 29 Jul 2026 $5.72 30 Jul 2026 $5.76 31 Jul 2026 $5.30 3 Aug 2026 $5.00 4 Aug 2026 $5.05 5 Aug 2026 $5.27 6 Aug 2026 $5.22 7 Aug 2026 $5.36 10 Aug 2026 $5.36 11 Aug 2026 $5.21 12 Aug 2026 $5.04 13 Aug 2026 $4.60 14 Aug 2026 $4.73 17 Aug 2026 $4.79 18 Aug 2026 $4.77 19 Aug 2026 $4.92 20 Aug 2026 $4.66 21 Aug 2026 $4.68 24 Aug 2026 $4.59 25 Aug 2026 $4.67 26 Aug 2026 $4.78 27 Aug 2026 $4.81 28 Aug 2026 $5.11 31 Aug 2026 $5.21 1 Sep 2026 $5.23 2 Sep 2026 $5.80 3 Sep 2026 $5.83 4 Sep 2026 $5.96 8 Sep 2026 $5.33 9 Sep 2026 $4.91 10 Sep 2026 $4.72 11 Sep 2026 $4.52 14 Sep 2026 $4.47 15 Sep 2026 $4.23 16 Sep 2026 $4.14 17 Sep 2026 $4.13 18 Sep 2026 $4.07 21 Sep 2026 $4.08 22 Sep 2026 $4.13 23 Sep 2026 $3.76 24 Sep 2026 $3.72 25 Sep 2026 $3.92 28 Sep 2026 $3.96 29 Sep 2026 $3.86 30 Sep 2026 $3.84 1 Oct 2026 $3.79 2 Oct 2026 $3.58 5 Oct 2026 $3.59 6 Oct 2026 $3.79 7 Oct 2026 $3.62 8 Oct 2026 $3.53 9 Oct 2026 $3.65 Chevallard Daniel R. Chief Financial Officer Bought $50.02K 7 Nov 2025 · at $22.76 · 68.9% of stake MCCOLLUM JAMES W Director Bought $239.28K 7 Nov 2025 · at $22.79 Olsson Shawn Chief Commercial Officer Sold on a plan $261.02K 17 Nov 2025 · at $26.10 · 67.9% of stake George Jeffrey P. Director Bought $49.89K 27 Mar 2026 · at $8.92 Chevallard Daniel R. Chief Financial Officer Bought $64.28K 27 Mar 2026 · at $8.57 · 139% of stake Schimmelpennink Evert B. President, CEO and Secretary Bought $251.41K 27 Mar 2026 · at $8.95 · 57.1% of stake
5 buys0 sales at will1 planned sale

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$19.09M
Net income
$82.13M
Free cash flow
$70.00M
Operating margin
-477.5%
Net margin
-430.3%
Return on equity
-28.9%
Return on capital
-25.3%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -68M FY20 Fiscal year 2020 Revenue $0.00 Net income $68.37M Margin n/a 0K -71M FY21 Fiscal year 2021 Revenue $0.00 Net income $70.76M Margin n/a 0K -101M FY22 Fiscal year 2022 Revenue $0.00 Net income $101.05M Margin n/a 0K -70M FY23 Fiscal year 2023 Revenue $0.00 Net income $69.97M Margin n/a 0K -50M FY24 Fiscal year 2024 Revenue $0.00 Net income $49.77M Margin n/a 19M -82M FY25 Fiscal year 2025 Revenue $19.09M Net income $82.13M Margin -430.3%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
27 Mar 2026 Schimmelpennink Evert B.
President, CEO and Secretary
Bought $251.41K 57.1%
27 Mar 2026 Chevallard Daniel R.
Chief Financial Officer
Bought $64.28K 139%
27 Mar 2026 George Jeffrey P.
Director
Bought $49.89K opened
17 Nov 2025 Olsson Shawn
Chief Commercial Officer
Sold on a plan $261.02K 67.9%
7 Nov 2025 MCCOLLUM JAMES W
Director
Bought $239.28K opened
7 Nov 2025 Chevallard Daniel R.
Chief Financial Officer
Bought $50.02K 68.9%